Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

ANTI-PD-1 Treatment in a Family with Constitutional Mismatch Repair Deficiency Syndrome with Multiple Cancers from Turkey. Is Cancer Immunoprevention with Checkpoint Inhibitors HAS a Role in CASES with Homozygous Mutationis

Emel Unal, Derya Ozyoruk, Nurdan Tacyildiz, Ferda Pi̇narli̇, A Erdogan, S Hanalioglu, Arzu Erdem, Meral Beksac, MD

Blood (2019) 134 (Supplement_1): 5632.

https://doi.org/10.1182/blood-2019-130102

Published: 2019

Journal Articles

Children with Juvenile Myelomonocytic Leukemia (JMML); A Single Center Experience

Özlem Satirer, MD, Selin Aytac, Baris Kuskonmaz, MD, Sule Unal, Fatma Gumruk, MD, Charlotte Niemeyer, MD, Mualla Cetin

Blood (2018) 132 (Supplement 1): 5527.

https://doi.org/10.1182/blood-2018-99-119585

Published: 2018

Journal Articles

A Novel Therapy Protocol Improves Outcomes of Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia Patients Using Hypomethylation of Decitabine

Zhiyong Peng, MD, Xiaoqin Feng, PhD, Huaying Liu, MD, Yuelin He, Jianyun Liao, MD, Xiaoting Liu, Chunfu Li, MD

Blood (2018) 132 (Supplement 1): 5778.

https://doi.org/10.1182/blood-2018-99-114777

Published: 2018

Journal Articles

RAS-MPAK Pathway Signaling in Health and Disease

Qing Li, MD PhD

Blood (2018) 132 (Supplement 1): SCI-40.

https://doi.org/10.1182/blood-2018-99-109378

Published: 2018

Journal Articles

Inherited Disorders of the Ras-MAPK Pathway

Christian P. Kratz, MD, Martin Zenker, MD

Blood (2018) 132 (Supplement 1): SCI-41.

https://doi.org/10.1182/blood-2018-99-109379

Published: 2018

Journal Articles

Hypomethylation of Decitabine Improved Outcomes of Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia

Zhiyong Peng, MD, Xiaoqin Feng, PhD, Yuelin He, Yuchen Lin, Jianyun Liao, Xuedong Wu, MD, Jiaqi Chen, MD, Chunfu Li, MD

Blood (2017) 130 (Supplement 1): 3232.

https://doi.org/10.1182/blood.V130.Suppl_1.3232.3232

Published: 2017

Journal Articles

Aberrant HCK Survival Signaling By Mutated MYD88 Requires PAX5 in Waldenstrom's Macroglobulinemia and ABC DLBCL Cells

Xia Liu, MD, Jiaji Chen, BS, Manit Munshi, MS, Lian Xu, Nickolas Tsakmaklis, BA, Maria Demos, BS, Amanda Kofides, BS, Maria Luisa Guerrera, MD, Gloria Chan, MS, Christopher Patterson, MAcc, Joshua Gustine, Jorge J. Castillo, MD, Zachary Hunter, PhD, Steven P Treon, MDPhDFRCP, Guang Yang, PhD

Blood (2017) 130 (Supplement 1): 1199.

https://doi.org/10.1182/blood.V130.Suppl_1.1199.1199

Published: 2017

Journal Articles

Myeloproliferative Disease and Myeloid Leukemia in Dnmt3a Haploinsufficient Mice

Christopher B Cole, Angela M. Verdoni, PhD, Gue Su Chang, PhD, Chris Miller, PhD, Timothy J. Ley, MD

Blood (2014) 124 (21): 890.

https://doi.org/10.1182/blood.V124.21.890.890

Published: 2014

Journal Articles

An ENU Mutagenesis Screen of FLT3-ITD Knock-in Mice Identifies Novel Gene Mutations That Lead to an Exacerbated Myeloproliferative Neoplasm

Anna L Brown, PhD, Teresa Sadras, PhD, Grant A Engler, BSc (Hons), Robert Tunningley, PhD, Jennifer Kofler, BSc, Paul J Leo, PhD, Jesse Cheah, BSc, Adrienne Laskowski, BSc, Ann Frazier, PhD, David Stroud, PhD, Michael Ryan, PhD, David Thorburn, PhDFHGSA FFSc(RCPA), D Gary Gilliland, MDPhD, Ian D Lewis, MBBS, PhD, Thomas J Gonda, PhD, Richard J D'Andrea, PhD

Blood (2014) 124 (21): 3591.

https://doi.org/10.1182/blood.V124.21.3591.3591

Published: 2014

Journal Articles

Mutational Profiling Of Myeloid Malignancies For Prediction Of Disease Relapse Following Allogeneic Stem Cell Transplantation

Alan M Hanash, MD, PhD, Sean M. Devlin, PhD, Molly Maloy, MA, Kristina M. Knapp, BS, Vincent A. Miller, MD, Doron Lipson, PhD, Philip J. Stephens, PhD, Geoff A Otto, PhD, Roman Yelensky, PhD, Michelle K. Nahas, PhD, Kai Wang, MD PhD, Ross L. Levine, MD, Marcel R.M. van den Brink, MD, PhD, Ann A. Jakubowski, MD, PhD

Blood (2013) 122 (21): 2096.

https://doi.org/10.1182/blood.V122.21.2096.2096

Published: 2013

Journal Articles

JMML Revisited: Role Und Outcome of Hematopoietic Stem Cell Transplantation in Subtypes of Juvenile Myelomonocytic Leukemia (JMML)

Blood (2012) 120 (21): 955.

https://doi.org/10.1182/blood.V120.21.955.955

Published: 2012

Journal Articles

Haploinsufficiency of Nf1 in Myeloid Lineages Contributes to Neurofibromatosis Type 1 Associated Skeletal Deficits

Steven D. Rhodes, Yongzheng He, M.D., Shi Chen, Hao Yang, Keshav M. Menon, Karl Staser, Ph.D., Xianlin Yang, Khalid S. Mohammad, M.D. Ph.D., Theresa Guise, M.D., Mingjiang Xu, M.D., Ph.D., Feng-chun Yang, M.D., Ph.D.

Blood (2012) 120 (21): 830.

https://doi.org/10.1182/blood.V120.21.830.830

Published: 2012

Journal Articles

Normal Hematopoiesis and Neurofibromin -Deficient Myeloproliferative Disease Require Erk

Karl Staser, PhD, Yi Zeng, MD, PhD, Su-jung Park, PhD, Steven D. Rhodes, Yongzheng He, M.D., Matthew A. Shew, Jeff Gehlhausen, Donna Cerabona, Shi Chen, Zejin Sun, MD, PhD, Grzegorz Nalepa, MD, PhD, Feng-chun Yang, M.D., Ph.D., D. Wade Clapp, MD

Blood (2012) 120 (21): 704.

https://doi.org/10.1182/blood.V120.21.704.704

Published: 2012

Journal Articles

MEK Inhibition Modulates the Growth of Nf1 mutant Hematopoietic Cells and Induces Clinical Improvement in a Murine Model of Juvenile Myelomonocytic Leukemia (JMML)

Tiffany Y. Chang, MD, Kimberly Krisman, BA, Emily Rose Harding-Theobald, BA, Benjamin S. Braun, MD, PhD, Kevin M. Shannon, MD

Blood (2011) 118 (21): 797.

https://doi.org/10.1182/blood.V118.21.797.797

Published: 2011

Journal Articles

Acute Lymphoblastic Leukemia Natural History in Neurofibromatosis Type 1 Monozygotic Twins

Marta Galbiati, Antonella Lettieri, Simona Songia, Cristina Morerio, Concetta Micalizzi, Carlo Dufour, MD, Andrea Biondi, MD, Giovanni Cazzaniga

Blood (2011) 118 (21): 2414.

https://doi.org/10.1182/blood.V118.21.2414.2414

Published: 2011

Journal Articles

Deletion of the Tumor Suppressor Gene NF1 Is Found In 3.5% of 485 De Novo Adult Myeloid Leukemia and Is Correlated with Unfavourable Cytogenetic: On Behalf of the ALFA Group

Blood (2010) 116 (21): 4171.

https://doi.org/10.1182/blood.V116.21.4171.4171

Published: 2010

Journal Articles

ITD-Flt3 Enhances Migration of Hematopoietic Cells through Aberrant CXCR4 Signaling Pathways Overlapping but Functionally Distinct From SDF1/CXCR4 Signaling Axis in Normal Hematopoietic Cells.

Seiji Fukuda, MD, PhD, Satomi Mori, MS, Mariko Abe, MD, Seiji Yamaguchi, MD, Louis M. Pelus, PhD

Blood (2009) 114 (22): 2383.

https://doi.org/10.1182/blood.V114.22.2383.2383

Published: 2009

Journal Articles

Mast Cells and Tumor Progression.

D. Wade Clapp, MD, Fengchun Yang, MD, PhD, David A. Ingram, Jr., MD, Kent A. Robertson, MD, PhD, Gary D. Hutchins, PhD, Luis F. Parada, PhD

Blood (2009) 114 (22): SCI-33.

https://doi.org/10.1182/blood.V114.22.SCI-33.SCI-33

Published: 2009

Journal Articles

Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia.

Blood (2009) 114 (22): 310.

https://doi.org/10.1182/blood.V114.22.310.310

Published: 2009

Journal Articles

Deletion of the Tumor Suppressor Gene NF1 Is An Alternative Mechanism for Aberrant Activation of the RAS Pathway and Is Found in 11% of Acute Myeloid Leukemia.

Claudia Haferlach, MD, Alexander Kohlmann, PhD, Sonja Schindela, Wolfgang Kern, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2009) 114 (22): 401.

https://doi.org/10.1182/blood.V114.22.401.401

Published: 2009

NARROW

ANTI-PD-1 Treatment in a Family with Constitutional Mismatch Repair Deficiency Syndrome with Multiple Cancers from Turkey. Is Cancer Immunoprevention with Checkpoint Inhibitors HAS a Role in CASES with Homozygous Mutationis

Children with Juvenile Myelomonocytic Leukemia (JMML); A Single Center Experience

A Novel Therapy Protocol Improves Outcomes of Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia Patients Using Hypomethylation of Decitabine

RAS-MPAK Pathway Signaling in Health and Disease

Inherited Disorders of the Ras-MAPK Pathway

Hypomethylation of Decitabine Improved Outcomes of Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia

Aberrant HCK Survival Signaling By Mutated MYD88 Requires PAX5 in Waldenstrom's Macroglobulinemia and ABC DLBCL Cells

Myeloproliferative Disease and Myeloid Leukemia in Dnmt3a Haploinsufficient Mice

An ENU Mutagenesis Screen of FLT3-ITD Knock-in Mice Identifies Novel Gene Mutations That Lead to an Exacerbated Myeloproliferative Neoplasm

Mutational Profiling Of Myeloid Malignancies For Prediction Of Disease Relapse Following Allogeneic Stem Cell Transplantation

JMML Revisited: Role Und Outcome of Hematopoietic Stem Cell Transplantation in Subtypes of Juvenile Myelomonocytic Leukemia (JMML)

Haploinsufficiency of Nf1 in Myeloid Lineages Contributes to Neurofibromatosis Type 1 Associated Skeletal Deficits

Normal Hematopoiesis and Neurofibromin -Deficient Myeloproliferative Disease Require Erk

MEK Inhibition Modulates the Growth of Nf1 mutant Hematopoietic Cells and Induces Clinical Improvement in a Murine Model of Juvenile Myelomonocytic Leukemia (JMML)

Acute Lymphoblastic Leukemia Natural History in Neurofibromatosis Type 1 Monozygotic Twins

Deletion of the Tumor Suppressor Gene NF1 Is Found In 3.5% of 485 De Novo Adult Myeloid Leukemia and Is Correlated with Unfavourable Cytogenetic: On Behalf of the ALFA Group

ITD-Flt3 Enhances Migration of Hematopoietic Cells through Aberrant CXCR4 Signaling Pathways Overlapping but Functionally Distinct From SDF1/CXCR4 Signaling Axis in Normal Hematopoietic Cells.

Mast Cells and Tumor Progression.

Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia.

Deletion of the Tumor Suppressor Gene NF1 Is An Alternative Mechanism for Aberrant Activation of the RAS Pathway and Is Found in 11% of Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only